What is Ava?
Ava is a digital health company that leverages artificial intelligence and clinical research to advance women's reproductive health. Headquartered across Zurich, San Francisco, Belgrade, and Makati, the company's core offering is a fertility tracking sensor bracelet. This device accurately detects a woman's five most fertile days in real-time with 90% accuracy, while simultaneously providing personalized insights into reproductive health and pregnancy. Ava's approach integrates cutting-edge technology with a deep understanding of women's health needs, positioning it as a key player in the femtech sector.
How much funding has Ava raised?
Ava has raised a total of $42.3M across 3 funding rounds:
Angel/Seed
$2.6M
Series A
$9.7M
Series B
$30M
Angel/Seed (2015): $2.6M with participation from Zu00fcrcher Kantonalbank and Swisscom
Series A (2016): $9.7M led by Polytech Ventures, Blue Ocean Ventures, Zürcher Kantonalbank, Swisscom, and Global Sources
Series B (2018): $30M supported by Blue Ocean Ventures, Global Sources, Zürcher Kantonalbank, SVC Ltd., Swisscom, btov, and Polytech Ventures
Key Investors in Ava
Polytech Ventures
Polytech Ventures is a Swiss investment firm specializing in growing innovative companies across various tech sectors, including Healthtech, providing both capital and advisory services.
Blue Ocean Ventures
BlueOcean Ventures focuses on early-stage medical device and life science companies, offering strategic guidance and financial backing to emerging ventures in healthcare and technology.
Zürcher Kantonalbank
Zürcher Kantonalbank is a leading Swiss universal bank providing a comprehensive range of financial products and services, including business financing and investment solutions.
What's next for Ava?
With substantial backing and a clear product-market fit, Ava is poised for continued expansion and innovation. The company's Series B financing, in particular, signals a phase of scaling operations, further product development, and potentially broader market penetration. Future strategic moves may involve enhancing AI algorithms, expanding clinical research partnerships, and developing new features to support women throughout their reproductive journeys. The company's focus on data-driven insights and accuracy in fertility prediction positions it well to capitalize on the increasing demand for personalized health technologies.
See full Ava company page
